Strategic Partnership Charter Research's collaboration with Eli Lilly on the TRAILBLAZER 3 prevention trial indicates a strong capability and reputation in clinical research services, positioning them as a potential partner for other pharmaceutical companies seeking expertise in clinical trials and drug development.

Growth Potential With an estimated revenue between 25 million and 50 million and a relatively small yet focused employee base, Charter Research presents opportunities for tailored research service offerings and expansion into new therapeutic areas tailored to client needs.

Technology Usage The company's adoption of modern technology stacks including React, JSON-LD, and social media channels suggests openness to digital solutions, enabling the possibility to offer cutting-edge data management, patient engagement, or virtual trial services.

Geographic Focus Located in Orlando with active trial sites in Lady Lake and Winter Park, Charter Research has a strong regional presence in Florida, which can be leveraged to identify opportunities in local or regional clinical research projects and partnerships.

Industry Positioning Specializing in research services with recent high-profile partnerships, Charter Research is well positioned to attract biotechs and pharmaceutical firms looking for reliable and innovative clinical trial partners, representing sales growth prospects in the research and development sector.